Results 141 to 150 of about 28,317 (294)

Incidence of Human Infection with Onchocerciasis in Different Communities in Relation to the Incidence and Type of the Ocular Lesions [PDF]

, 1955
F. H. Budden
openalex   +1 more source

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes

PLoS Neglected Tropical Diseases, 2019
1 Global Health Institute, University of Antwerp, Antwerp, Belgium, 2 Neglected and Disabling Diseases of Poverty Consultant, Kent, United Kingdom, 3 Neglected Tropical Diseases Control Programme, Ministry of Health, Kampala, Uganda, 4 National institute
R. Colebunders, J. S. Siewe Fodjo, A. Hopkins, A. Hotterbeekx, T. Lakwo, A. Kalinga, M. Y. Logora, M. Basáñez   +7 more
semanticscholar   +1 more source

Issue Information

Epilepsia Open, Volume 10, Issue 1, Page 1-9, February 2025.
wiley   +1 more source

Onchocerciasis [PDF]

, 1927
N. A. Dyce Sharp, William Prout
openalex   +1 more source

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025

Clinical Infectious Diseases, 2019
Background Onchocerciasis elimination through mass drug administration (MDA) is hampered by coendemicity of Loa loa, as people with high L. loa microfilariae (mf) density can develop serious adverse events (SAEs) after ivermectin treatment.
Natalie V. S. Vinkeles Melchers, L. Coffeng, M. Boussinesq, Bélen Pedrique, S. Pion, A. Tekle, Honorat G M Zoure, S. Wanji, J. Remmé, W. Stolk   +9 more
semanticscholar   +1 more source

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol

Infectious Diseases of Poverty, 2018
Background Nodding syndrome (NS) is a devastating epileptic illness of unknown aetiology mainly affecting children 5–15 years of age. Head nodding distinguishes NS from other forms of epilepsy.
Gasim Abd-Elfarag, Makoy Yibi Logora, Jane Y. Carter, Morrish Ojok, Jackson Songok, Sonia Menon, Ferdinand Wit, Richard Lako, Robert Colebunders   +8 more
doaj   +1 more source

Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: Current perspectives

The Indian journal of medical research, 2019
Onchocerciasis and lymphatic filariasis (LF) are human filarial diseases belonging to the group of neglected tropical diseases, leading to permanent and long-term disability in infected individuals in the endemic countries such as Africa and India ...
W. A. Wan Sulaiman, Joseph Kamtchum-Tatuene, M. H. Mohamed, V. Ramachandran, S. Ching, Sazlyna Mohd Sazlly Lim, Hasnur Zaman Hashim, Liyana Najwa Inche Mat, F. Hoo, H. Basri   +9 more
semanticscholar   +1 more source

Evaluation of microfilaricidal effects in the cornea from topically applied drugs in ocular onchocerciasis: Trials with levamisole and mebendazole. [PDF]

, 1978
B. R. Jones, John Anderson, H. Fuglsang
openalex   +1 more source

Onchocerciasis

Definitions, 2020

semanticscholar   +1 more source

Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol

Parasites & Vectors, 2019
Background Onchocerciasis is a priority neglected tropical disease targeted for elimination by 2025. The standard strategy to combat onchocerciasis is annual Community-Directed Treatment with ivermectin (CDTi). Yet, high prevalence rates and transmission
Samuel Wanji, Theobald Mue Nji, Louise Hamill, Laura Dean, Kim Ozano, Abdel J. Njouendou, Raphael A. Abong, Elisabeth Dibando Obie, Andrew Amuam, Relindis Ekanya, Winston Patrick Chounna Ndongmo, Bertrand L. Ndzeshang, Ebua Gallus Fung, Dum-Buo Nnamdi, Desmond Akumtoh Nkimbeng, Samuel Teghen, Emmanuel Kah, Helen Piotrowski, Armelle Forrer, Jahangir A. M. Khan, Maame E. Woode, Louis Niessen, Victoria Watson, Zakariaou Njoumemi, Michele E. Murdoch, Rachael Thomson, Sally Theobald, Peter Enyong, Joseph D. Turner, Mark J. Taylor   +29 more
doaj   +1 more source